Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

They use the body's own immune system to detect and kill cancer cells "Immunotherapies have been very promising and has ...

ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.

Sunshine Coast University Hospital to see $2.3 million service expansion. In a Southern Hemisphere first, the service now offers a new Cone Beam CT ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...